Intelligent Bio Solutions (INBS) Receivables - Other (2020 - 2024)
Intelligent Bio Solutions has reported Receivables - Other over the past 5 years, most recently at $332471.0 for Q1 2024.
- Quarterly results put Receivables - Other at $332471.0 for Q1 2024, down 42.52% from a year ago — trailing twelve months through Mar 2024 was $332471.0 (down 42.52% YoY), and the annual figure for FY2023 was $498758.0, up 1860.3%.
- Receivables - Other for Q1 2024 was $332471.0 at Intelligent Bio Solutions, up from $289167.0 in the prior quarter.
- Over the last five years, Receivables - Other for INBS hit a ceiling of $1.0 million in Q2 2021 and a floor of $7050.0 in Q3 2022.
- Median Receivables - Other over the past 5 years was $203976.0 (2022), compared with a mean of $323506.9.
- Biggest five-year swings in Receivables - Other: surged 8386.06% in 2021 and later crashed 99.28% in 2022.
- Intelligent Bio Solutions' Receivables - Other stood at $12084.0 in 2020, then soared by 133.01% to $28157.0 in 2021, then soared by 124.39% to $63182.0 in 2022, then skyrocketed by 357.67% to $289167.0 in 2023, then grew by 14.98% to $332471.0 in 2024.
- The last three reported values for Receivables - Other were $332471.0 (Q1 2024), $289167.0 (Q4 2023), and $559588.0 (Q3 2023) per Business Quant data.